Fraser Institute Media Advisory: How are Canadians at risk from counterfeit pharmaceuticals? New study coming Thursday, Feb. 8
VANCOUVER, British Columbia, Feb. 07, 2018 (GLOBE NEWSWIRE) -- On Thursday, Feb. 8, the Fraser Institute will release a new study examining counterfeit pharmaceutical drugs.
Pharmaceutical Counterfeiting: Endangering Public Health, Society, and the Economy spotlights how and why Canadian patients are at risk from counterfeit drugs, and the size of the problem in Canada and around the world.
A news release with additional information will be issued via GlobeNewswire on Feb. 8 at 5:00 a.m. (Eastern).
MEDIA CONTACTS:
Dr. Kristina M. L. Acri née Lybecker, Senior Fellow
Fraser Institute
To arrange media interviews or for more information, please contact:
Bryn Weese
Media Relations Specialist, Fraser Institute
(604) 688-0221 ext. 589
[email protected]
Follow the Fraser Institute on Twitter | Like us on Facebook
The Fraser Institute is an independent Canadian public policy research and educational organization with offices in Vancouver, Calgary, Toronto, and Montreal and ties to a global network of think-tanks in 87 countries. Its mission is to improve the quality of life for Canadians, their families and future generations by studying, measuring and broadly communicating the effects of government policies, entrepreneurship and choice on their well-being. To protect the Institute's independence, it does not accept grants from governments or contracts for research. Visit www.fraserinstitute.org.
News published on and distributed by:
